Publicacions en què col·labora amb Núria Sala Serra (26)

2021

  1. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort

    Gut Microbes, Vol. 13, Núm. 1, pp. 1-14

  2. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score

    BMC Medicine, Vol. 19, Núm. 1

  3. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study

    International Journal of Cancer, Vol. 148, Núm. 3, pp. 609-625

  4. Plasma Vitamin C and type 2 diabetes: Genome-wide association study and mendelian randomization analysis in European populations

    Diabetes Care, Vol. 44, Núm. 1, pp. 98-106

2019

  1. vitamin D-related genes, blood vitamin D levels and colorectal cancer risk in western european populations

    Nutrients, Vol. 11, Núm. 8

2017

  1. Aromatic DNA adducts and breast cancer risk: A case-cohort study within the EPIC-Spain

    Carcinogenesis, Vol. 38, Núm. 7, pp. 691-698

2016

  1. Influence of dopaminergic system genetic variation and lifestyle factors on excessive alcohol consumption

    Alcohol and Alcoholism, Vol. 51, Núm. 3, pp. 258-267

  2. Serum endotoxins and flagellin and risk of colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC) cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 2, pp. 291-301

2015

  1. Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma

    Cancer Causes and Control, Vol. 26, Núm. 12, pp. 1845-1855

  2. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic Lymphocytic Leukemia: A prospective analysis using plasma soluble CD23

    Cancer Epidemiology Biomarkers and Prevention, Vol. 24, Núm. 3, pp. 538-545

2014

  1. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort

    Carcinogenesis, Vol. 35, Núm. 9, pp. 2047-2054

  2. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity

    Diabetes, Vol. 63, Núm. 12, pp. 4378-4387

  3. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

    Blood, Vol. 124, Núm. 4, pp. 530-535

  4. Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibility

    Clinical and Translational Oncology, Vol. 16, Núm. 1, pp. 107-112

2012

  1. Aromatic DNA adducts and risk of gastrointestinal cancers: A case-cohort study within the EPIC-Spain

    Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 685-692

  2. Association of alcohol dehydrogenase polymorphisms and life-style factors with excessive alcohol intake within the Spanish population (EPIC-Spain)

    Addiction, Vol. 107, Núm. 12, pp. 2117-2127

  3. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST study

    International Journal of Cancer, Vol. 130, Núm. 10, pp. 2417-2427

  4. Sources of pre-analytical variations in yield of DNA extracted from blood samples: Analysis of 50,000 DNA samples in EPIC

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

    Cancer Letters, Vol. 311, Núm. 1, pp. 85-95

  2. Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

    European Journal of Cancer, Vol. 47, Núm. 3, pp. 420-427